Pharmacodynamic Study of TPN171H Tablets in Patients With Mild to Moderate Erectile Dysfunction

PHASE2CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

January 4, 2023

Study Completion Date

February 17, 2023

Conditions
Erectile Dysfunction
Interventions
DRUG

TPN171H 2.5mg

TPN171H 2.5mg is recommended to take warm water on an empty stomach (2 hours or more after dinner)

DRUG

TPN171H 5mg

TPN171H 5mg is recommended to take warm water on an empty stomach (2 hours or more after dinner)

DRUG

TPN171H 10mg

TPN171H 10mg is recommended to take warm water on an empty stomach (2 hours or more after dinner)

DRUG

Placebo 5mg

Placebo 5mg is recommended to take warm water on an empty stomach (2 hours or more after dinner)

DRUG

Placebo 10mg

Placebo 10mg is recommended to take warm water on an empty stomach (2 hours or more after dinner)

Trial Locations (8)

35004

The First Affiliated Hospital of Fujian Medical University, Fuzhou

100191

Peking University Third Hospital, Beijing

116011

The Second Hospital of Dalian Medical University, Dalian

130021

The First Hospital of Jilin University, Changchun

210008

Nanjing Drum Tower Hospital, Nanjing

215006

The First Affiliated Hospital of Soochow University, Suzhou

230022

The First Affiliated Hospital of Anhui Medical University, Hefei

450003

Henan Provincial People's Hospital, Zhenzhou

All Listed Sponsors
lead

Vigonvita Life Sciences

INDUSTRY